Thus, in 2023, Fiterman generated a RON193 million business and a RON23 million profit, having the same average number of employees, of over 230.
The financial results position the company among the ten largest drug manufacturers in Romania, on a market that however counts on few companies producing drugs locally.
Fiterman Pharma competes locally with Terapia Cluj, Zentiva Bucuresti, Antibiotice Iasi.
(English version by Catalina Apostoiu)